Maria O’Donovan

990 total citations
26 papers, 376 citations indexed

About

Maria O’Donovan is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Maria O’Donovan has authored 26 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 7 papers in Gastroenterology. Recurrent topics in Maria O’Donovan's work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (13 papers) and Esophageal and GI Pathology (10 papers). Maria O’Donovan is often cited by papers focused on Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (13 papers) and Esophageal and GI Pathology (10 papers). Maria O’Donovan collaborates with scholars based in United Kingdom, Poland and United States. Maria O’Donovan's co-authors include Rebecca C. Fitzgerald, Massimiliano di Pietro, C. Twomey, Kieran O’Connor, B. Cryan, Mark Kingston, Denis O’Mahony, Karol Nowicki-Osuch, Ginny Devonshire and Lizhe Zhuang and has published in prestigious journals such as Science, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Maria O’Donovan

25 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria O’Donovan United Kingdom	11	220	152	74	67	54	26	376
Huang‐Wei Xu Taiwan	6	155 0.7×	84 0.6×	154 2.1×	57 0.9×	32 0.6×	9	358
Simcha Weissman United States	10	193 0.9×	114 0.8×	47 0.6×	151 2.3×	38 0.7×	66	384
Xiaosun Liu China	7	233 1.1×	143 0.9×	236 3.2×	85 1.3×	30 0.6×	13	418
Yun Ju Jo South Korea	11	203 0.9×	96 0.6×	57 0.8×	68 1.0×	47 0.9×	45	352
Sílvia Silva Portugal	12	119 0.5×	90 0.6×	48 0.6×	60 0.9×	22 0.4×	26	347
Yoshiharu Uno Japan	12	203 0.9×	255 1.7×	37 0.5×	175 2.6×	123 2.3×	31	512
Bojan Tepeš Slovenia	12	291 1.3×	108 0.7×	30 0.4×	81 1.2×	97 1.8×	49	389
Masaki Katsurahara Japan	11	320 1.5×	248 1.6×	37 0.5×	102 1.5×	128 2.4×	58	472
Yogesh M. Shastri Germany	8	85 0.4×	83 0.5×	26 0.4×	74 1.1×	19 0.4×	10	256
M. Cobo Spain	8	93 0.4×	215 1.4×	37 0.5×	199 3.0×	39 0.7×	20	342

Countries citing papers authored by Maria O’Donovan

Since Specialization

Citations

This map shows the geographic impact of Maria O’Donovan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria O’Donovan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria O’Donovan more than expected).

Fields of papers citing papers by Maria O’Donovan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria O’Donovan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria O’Donovan. The network helps show where Maria O’Donovan may publish in the future.

Co-authorship network of co-authors of Maria O’Donovan

This figure shows the co-authorship network connecting the top 25 collaborators of Maria O’Donovan. A scholar is included among the top collaborators of Maria O’Donovan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria O’Donovan. Maria O’Donovan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nowicki-Osuch, Karol, Lizhe Zhuang, Tik Shing Cheung, et al.. (2023). Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. Cancer Discovery. 13(6). 1346–1363. 32 indexed citations

Dieninytė, Eglė, et al.. (2023). Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries. PLoS ONE. 18(6). e0287587–e0287587. 4 indexed citations

Lee, Colin Y.C., Anne Lydon, Susan Richardson, et al.. (2022). Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. The Lancet Oncology. 24(1). 107–116. 28 indexed citations

Vithayathil, Mathew, Inés Modolell, Jacobo Ortiz‐Fernández‐Sordo, et al.. (2022). Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett’s Esophagus. Clinical Gastroenterology and Hepatology. 20(11). 2514–2523.e3. 14 indexed citations

Tan, Wei Keith, et al.. (2022). Quantification of TFF3 expression from a non-endoscopic device predicts clinically relevant Barrett's oesophagus by machine learning. EBioMedicine. 82. 104160–104160. 4 indexed citations

Paterson, Anna, et al.. (2021). Thyroid diagnostic modalities (fine needle aspiration and core needle biopsy) with histology correlation: a tertiary centre experience. Journal of Clinical Pathology. 75(9). 620–626. 2 indexed citations

Nowicki-Osuch, Karol, Lizhe Zhuang, Sriganesh Jammula, et al.. (2021). Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition. Science. 373(6556). 760–767. 92 indexed citations

Eluri, Swathi, Anna Paterson, Brianna N. Lauren, et al.. (2021). Utility and Cost-Effectiveness of a Nonendoscopic Approach to Barrett’s Esophagus Surveillance After Endoscopic Therapy. Clinical Gastroenterology and Hepatology. 20(2). e51–e63. 2 indexed citations

Januszewicz, Władysław, Nastazja Pilonis, Maria O’Donovan, et al.. (2021). The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study. Gastrointestinal Endoscopy. 94(2). 263–270.e2. 12 indexed citations

10.

Vithayathil, Mathew, Inés Modolell, Jacobo Ortiz Fernández‐Sordo, et al.. (2021). 227 CONFOCAL LASER ENDOMICROSCOPY IN COMBINATION WITH MOLECULAR BIOMARKERS FOR THE DIAGNOSIS OF INCONSPICUOUS DYSPLASIA IN BARRETT'S ESOPHAGUS: A RANDOMISED CROSS-OVER TRIAL. Gastroenterology. 160(6). S–48.

11.

Januszewicz, Władysław, Vinod Vijay Subhash, Hamza Chettouh, et al.. (2020). The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus. EBioMedicine. 58. 102877–102877. 2 indexed citations

12.

Paterson, Anna, Marcel Gehrung, Rebecca C. Fitzgerald, & Maria O’Donovan. (2019). Role of TFF3 as an adjunct in the diagnosis of Barrett's esophagus using a minimally invasive esophageal sampling device—The Cytosponge ^TM. Diagnostic Cytopathology. 48(3). 253–264. 17 indexed citations

13.

Tan, Wei Keith, et al.. (2018). Comparative outcomes of radiofrequency ablation for Barrett's oesophagus with different baseline histology. United European Gastroenterology Journal. 6(5). 662–668. 2 indexed citations

14.

Silva, Nadeera de, Anna Paterson, Maria Secrier, et al.. (2015). Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma. British Journal of Cancer. 113(9). 1305–1312. 17 indexed citations

15.

Shariff, Mohammed, Sybil Varghese, Maria O’Donovan, et al.. (2015). Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett’s esophagus. Endoscopy. 48(2). 110–116. 29 indexed citations

16.

Lao‐Sirieix, Pierre, Maria O’Donovan, Marco Novelli, et al.. (2015). 54 Evaluation of a Minimally-Invasive Cytosponge Esophageal Cell Collection System in Patients With Barrett's Esophagus. Gastroenterology. 148(4). S–16. 5 indexed citations

17.

Shariff, Mohammed, Massimiliano di Pietro, David F. Boerwinkel, et al.. (2012). 958 Time: A Prospective Study Combining Endoscopic Trimodal Imaging and Molecular Endpoints to Improve Risk Stratification in Barrett's Esophagus. Gastroenterology. 142(5). S–165. 5 indexed citations

18.

O’Connor, Kieran, Mark Kingston, Maria O’Donovan, et al.. (2004). Antibiotic prescribing policy and Clostridium difficile diarrhoea. QJM. 97(7). 423–429. 62 indexed citations

19.

Samuels, Brian L., Daniel A. Rushing, Sant P. Chawla, et al.. (2004). Randomized phase II study of trabectedin (ET-743) given by two different dosing schedules in patients (pts) with leiomyosarcomas (LMS) or liposarcomas (LPS) refractory to conventional doxorubicin and ifosfamide chemotherapy. Journal of Clinical Oncology. 22(14_suppl). 9000–9000. 14 indexed citations

20.

O’Donovan, Maria, et al.. (1986). Ketanserin, A 5 — HT antagonist, in symptomatic treatment of Carcinoid Syndrome. Irish Journal of Medical Science (1971 -). 155(12). 436–436. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact